metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Genética de las colestasis crónicas en la infancia
Información de la revista
Vol. 25. Núm. 7.
Páginas 475-480 (enero 2002)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 25. Núm. 7.
Páginas 475-480 (enero 2002)
Acceso a texto completo
Genética de las colestasis crónicas en la infancia
Visitas
5573
P. Jaraa,*, L. Álvarezb
a Servicio de Hepatología Infantil. Hospital Infantil La Paz. Madrid
b Laboratorio de Hepatología Molecular. Unidad de Investigación. Hospital Universitario La Paz. Madrid
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
E. Alagille, A. Estrada, M. Hadchouel, M. Gautier, M. Odievre, J.P. Dommergues.
Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia). Review of 80 cases.
J Pediatr, 109 (1987), pp. 195-200
[2.]
J.L.B. Byrne, M.J.E. Harrod, J.M. Friedman, P.N. Howard-Peebles.
Del(20p) with manifestations of ateriohepatic dysplasia.
Am J Med Genet, 24 (1986), pp. 673-678
[3.]
S. Schnittger, C. Hofers, P. Heideman, F. Beerman, I. Hansmann.
Molecular and cytogenetic analysis of an interstitial 20p deletion associated with syndromic intrahepatic ductular hypoplasia (Alagille syndrome).
Hum Genet, 83 (1989), pp. 239-244
[4.]
T. Oda, A.G. Elkahloun, B.L. Pike, K. Okajima, I.D. Krantz, A. Genin, et al.
Mutations in the human Jagged1 gene are responsible for Alagille syndrome.
Nat Genet, 16 (1997), pp. 235-242
[5.]
L. Li, I.D. Krantz, Y. Deng, A. Genin, A.B. Banta, C.C. Collins, et al.
Alagille syndrome is caused by mutations in Jagged1, which encodes a ligand for Notch1.
Nat Genet, 16 (1997), pp. 243-251
[6.]
S. Artavanis-Tsakonas, K. Matsuno, M.E. Fortini.
Notch signaling.
Science, 268 (1995), pp. 225-232
[7.]
E.A. Jones, M. Clement-Jones, D.I. Wilson.
Jagged1 expression in human embryos: correlation with the Alagille syndrome phenotype.
J Med Genet, 37 (2000), pp. 663-668
[8.]
C. Crosnier, T. Attie-Bitach, F. Encha-Razavi, S. Audollent, F. Soudy, M. Hadchouel, et al.
Jagged1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome.
Hepatology, 32 (2000), pp. 574-581
[9.]
A.A. Louis, E.P. Van Eyken, B.A. Harber, C. Hicks, G. Weinmaster, R. Taulb, et al.
Hepatic jagged expression studies.
Hepatology, 30 (1999), pp. 1269-1275
[10.]
I.D. Krantz, R.P. Colliton, A. Genin, E.B. Rand, L. Li, D.A. Piccoli, et al.
Spectrum and frecuency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.
Am J Human Genet, 62 (1998), pp. 1361-1369
[11.]
C. Crosnier, C. Driancourt, N. Raynaud, S. Dhorme-Pollet, N. Pollet, O. Bernard, et al.
Mutations in Jagged1 gene are predominantly sporadic in Alagille syndrome.
Gastroenterology, 116 (1999), pp. 1141-1148
[12.]
P. Jara.
Patología pediátrica.
Tratamiento de las enfermedades hepáticas, pp. p337-p345
[13.]
E.J. Hoffenberg, M.R. Narkewicz, J.M. Sondheimer, D.J. Smith, A. Silverman, R.J. Sokol.
Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy.
J Pediatr, 127 (1995), pp. 220-224
[14.]
A.G. Tzakis, J. Reyes, K. Tepetes, V. Tzoracoleftherakis, S. Todo, T. Starzl.
Liver transplantation for Alagillle's Syndrome.
Arch Surg, 128 (1993), pp. 337-339
[15.]
J. Cardona, D. Houssin, F. Gauthier, D. Devictor, J. Losay, M. Hadchouel, et al.
Liver transplantation in children with Alagille syndrome -a study of twelve cases.
Transplantation, 60 (1995), pp. 339-342
[16.]
R.J. Clayton, F.L. Iber, B.H. Ruebner, V.A. McKusick.
Byler disease: fatal familial intrahepatic cholestasis in an Amish kindred.
Am J Dis Child, 117 (1969), pp. 112-124
[17.]
E. Jaquemin, M. Dumont, O. Bernard, S. Erlinger, M. Hadchonel, et al.
Evidence for defective primary bile acid secretion in children with progressive familial intrahepatic cholestasis (Byler disease).
Eur J Pediatr, 153 (1994), pp. 424-428
[18.]
G.A. Kullak-Ublick, U. Beuers, G. Paumgartner.
Hepatobiliary transport.
J Hepatol, 32 (2000), pp. 3-18
[19.]
L.N. Bull, M.J.T. Van Eijk, L. Pawlikowska, J. De Young, J. Juiun, M. Liao, et al.
Identification of a P-type ATPase mutated in two forms of hereditary cholestasis.
Nat Genet, 18 (1998), pp. 219-224
[20.]
R. Thompson, P. Jansen.
Genetic defects in hepatocanalicular transports.
Semin Liver Dis, 20 (2000), pp. 365-372
[21.]
E.F. Eppen, S.W. Van Mil, J.M. De Vree, K.S. Mok, J.A. Juijn, R.P. Elferisk, et al.
FIC1, the protein affected in two forms of hereditary cholestasis is localized in the cholangiocyte and the canalicular membrane of the hepatocyte.
J Hepatol, 35 (2001), pp. 436-443
[22.]
S.S. Strautnieks, L.B. Bull, A.S. Knisely, S.A. Kocoshis, N. Dahl, H. Arnell, et al.
A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
Nat Genet, 20 (1998), pp. 233-238
[23.]
P.L.M. Jansen, S.S. Strautnieks, E. Jaquemin, M. Hadchouel, E.M. Sokal, J.E. Guido, et al.
Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Gastroenterology, 117 (1999), pp. 1370-1379
[24.]
J.F. Deleuze, E. Jacquemin, C. Dubuisson, D. Cresteil, M. Dumont, S. Erlinger, et al.
Defect of multidrug-resistance 3 expression in a subtype of progressive familial intrahepatic cholestasis.
Hepatology, 23 (1996), pp. 904-908
[25.]
J.M. De Vree, E. Jaquemin, E. Sturm, D. Cresteil, P.J. Bosma, J. Alen, et al.
Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis.
Proc Natl Acad Sci USA, 95 (1998), pp. 282-287
[26.]
P.H. Dixon, N. Weerasekera, K.J. Linton, O. Donaldson, J. Chambers, E. Egginton, et al.
Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
Hum Mol Genet, 9 (2000), pp. 1209-1217
[27.]
J.A. Bezerra, W.F. Ballasteri.
Intrahepatic cholestasis: order out of caos.
Gastroenterology, 117 (1999), pp. 1496-1498
[28.]
S. Erlinger.
Cholestasis.
Schiff's diseases of the liver, pp. p611-p629
[29.]
E.M. Alonso, D.C. Snover, A. Montag, E.K. Freese, P.F. Whitington.
Histologic pathology of the liver in progressive familial intrahepatic cholestasis.
J Pediatr Gastroenterol Nutr, 18 (1994), pp. 128-133
[30.]
G. Dinler, N. Kocak, H. Ozen, A. Yuce, F. Gurakan.
Ursodeoxycholic acid treatment in children with Byler disease.
Pediatr Int, 41 (1999), pp. 662-665
[31.]
E. Jacquemin, J.M.L. De Vree, D. Cresteil, E.M. Sokal, E. Sturm, M. Dumont, et al.
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Gastroenterology, 120 (2001), pp. 1448-1457
[32.]
O. Rosmorduc, B. Hermelin, R. Poupon.
MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelitiasis.
Gastroenterology, 120 (2001), pp. 1459-1467
[33.]
P.F. Whitington, D.K. Freese, E.M. Alonso, S.J. Schwarzenberg, H.L. Sharp.
Clinical and biochemical findings in progressive familial intrahepatic cholestasis.
J Pediatr Gastroenterol Nutr, 18 (1994), pp. 134-141
[34.]
I.D. Krantz, E.B. Rand, A. Genin, P. Hunt, D.A. Piccoli, N.B. Spinner.
Alagille syndrome.
J Med Genet, 34 (1997), pp. 152-157
[35.]
B.L. Shneider.
Genetic cholestatic syndromes.
J Pediatr Gastroenterol Nutr, 28 (1999), pp. 124-131
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos